Related Experiment Video
Updated: Mar 24, 2026
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
35.2K
[POSSIBILITIES OF THE RAOIOFREQUENCY ABLATION METHOD IN TREATMENT OF PULMONARY AND PLEURAL MALIGNANCIES].
Klinichna Khirurhiia
|March 8, 2016
Summary
Radiofrequency ablation (RFA) effectively treated 92% of patients with lung and pleural malignancies when surgery was not an option. This palliative treatment showed a 13% complication rate.
Area of Science:
- Oncology
- Interventional Radiology
- Pulmonology
Context:
- Pulmonary and pleural malignancies present significant treatment challenges, especially when radical surgical options are contraindicated.
- Minimally invasive techniques are increasingly explored for managing advanced thoracic cancers.
Purpose:
- To evaluate the efficacy and safety of radiofrequency ablation (RFA) for treating pulmonary and pleural malignancies in patients unsuitable for surgery.
- To determine the immediate positive response rate and complication incidence associated with RFA.
Summary:
- Radiofrequency ablation (RFA) was performed on 74 patients with pulmonary and pleural malignancies using the FOTEK-150 apparatus.
- An immediate positive effect was observed in 92% of patients, with a 13% complication rate.
- RFA demonstrated feasibility as a palliative treatment option when radical surgery is not possible.
Impact:
- Radiofrequency ablation (RFA) offers a viable palliative treatment for patients with advanced pulmonary and pleural malignancies, improving outcomes when curative surgery is not feasible.
- The study supports the use of RFA as an important tool in the management of thoracic malignancies, balancing efficacy with an acceptable complication profile.
